Mycobacterium szulgai Pulmonary Infection in an Immunocompromised Patient

Neves, Sara; Pos, Ema; Horta, Ana; Vasconcelos, António Ludgero

http://hdl.handle.net/10400.16/2965

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Neves-2023-Mycobacterium-szulgai-pulmonary-inf.pdf		436.69 KB	Adobe PDF	Download

Send Feedback

Authors

Neves, Sara

Pos, Ema

Horta, Ana

Vasconcelos, António Ludgero

Abstract(s)

Mycobacterium szulgai is a slow-growing nontuberculous mycobacterium (NTM). It was first described in 1972 and is responsible for less than 0.2% of all NTM infections. The most common presentation resembles pulmonary tuberculosis, but it may also present as an extrapulmonary disease. It primarily affects individuals with underlying lung disease or immunocompromising conditions. The increasing use of tumor necrosis factor-alpha inhibitors, such as adalimumab, is associated with an increased risk of serious infections. We report a case of Mycobacterium szulgai infection in a 23-year-old woman with a history of childhood pneumonia and Crohn's disease on adalimumab.

Keywords

adalimumab crohn`s disease mycobacterium szulgai nontuberculous mycobacteria (ntm) tumor necrosis factor-alpha (tnf-α) inhibitors

URI

http://hdl.handle.net/10400.16/2965

Citation

Neves S, Pos E, Horta A, Vasconcelos AL. Mycobacterium szulgai Pulmonary Infection in an Immunocompromised Patient. Cureus. 2023;15(12):e51388. doi:10.7759/cureus.51388